| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |